Is EUCRU or JNJ a better dividend investment in 2026?

EUCRU currently yields 19.96% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: EUCRU offers higher current income.

What is the dividend yield difference between EUCRU and JNJ?

EUCRU has a forward dividend yield of 19.96% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 16.60 percentage points.

Home › Compare › EUCRU vs JNJ

EUCRU vs JNJ: Dividend Comparison 2026

EUCRU yields 19.96% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EUCRU wins by $52.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

EUCRU

● Live price

19.96%

Share price

$10.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$72.8K

Annual income

$6,710.30

Full EUCRU calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — EUCRU vs JNJ

📍 EUCRU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EUCRU	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EUCRU + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EUCRU pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EUCRU

Annual income on $10K today (after 15% tax)

$1,696.61/yr

After 10yr DRIP, annual income (after tax)

$5,703.76/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, EUCRU beats the other by $5,000.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EUCRU + JNJ for your $10,000?

EUCRU: 50%JNJ: 50%

100% JNJ50/50100% EUCRU

Portfolio after 10yr

$46.4K

Annual income

$3,769.04/yr

Blended yield

8.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EUCRU

No analyst data

Altman Z

6.6

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EUCRU buys

JNJ buys

No recent congressional trades found for EUCRU or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEUCRUJNJ

Forward yield	19.96% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$72.8K ✓	$20.0K
Annual income after 10y	$6,710.30 ✓	$827.78
Total dividends collected	$41.4K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EUCRU vs JNJ ($10,000, DRIP)

Year	EUCRU Portfolio	EUCRU Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,696	$1,996.01	$10,676	$355.77	+$2.0K → EUCRU
2	$15,953	$2,368.35	$11,407	$389.39	+$4.5K → EUCRU
3	$19,851	$2,781.24	$12,198	$426.53	+$7.7K → EUCRU
4	$24,475	$3,234.40	$13,056	$467.62	+$11.4K → EUCRU
5	$29,915	$3,726.92	$13,987	$513.12	+$15.9K → EUCRU
6	$36,267	$4,257.31	$14,998	$563.56	+$21.3K → EUCRU
7	$43,629	$4,823.54	$16,098	$619.52	+$27.5K → EUCRU
8	$52,106	$5,423.11	$17,295	$681.69	+$34.8K → EUCRU
9	$61,806	$6,053.11	$18,599	$750.82	+$43.2K → EUCRU
10	$72,843	$6,710.30	$20,022	$827.78	+$52.8K → EUCRU

EUCRU vs JNJ: Complete Analysis 2026

EUCRU — Stock

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Full EUCRU Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this EUCRU vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EUCRU vs SCHD EUCRU vs JEPI EUCRU vs O EUCRU vs KO EUCRU vs MAIN EUCRU vs ABBV EUCRU vs MRK EUCRU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.